Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Debt to Equity (2022 - 2025)

Celularity (CELU) has disclosed Debt to Equity for 4 consecutive years, with -$0.21 as the latest value for Q3 2025.

  • On a quarterly basis, Debt to Equity changed N/A to -$0.21 in Q3 2025 year-over-year; TTM through Sep 2025 was -$0.21, a N/A change, with the full-year FY2024 number at $4.35, up 821.02% from a year prior.
  • Debt to Equity was -$0.21 for Q3 2025 at Celularity, up from -$1.6 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $4.35 in Q4 2024 to a low of -$7.08 in Q1 2025.
  • A 4-year average of -$0.28 and a median of $0.2 in 2022 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: surged 93.73% in 2023, then skyrocketed 821.02% in 2024.
  • Celularity's Debt to Equity stood at $0.19 in 2022, then soared by 149.64% to $0.47 in 2023, then surged by 821.02% to $4.35 in 2024, then tumbled by 104.9% to -$0.21 in 2025.
  • Per Business Quant, the three most recent readings for CELU's Debt to Equity are -$0.21 (Q3 2025), -$1.6 (Q2 2025), and -$7.08 (Q1 2025).